UCB Pharma SA, in association with Dr. Victor Biton, Principal Investigator,
is conducting a nationwide clinical trial to evaluate the effectiveness,
tolerability, and safety of a single dose of inhaled study medication
(alprazolam) for the rapid treatment of epilepsy in adolescents.

Participants must be:

*12-17 years old and accompanied by a Parent or Legal Guardian
*Previously diagnosed with Epilepsy *Able to stay over-night
*Assessed as meeting all other Inclusion/Exclusion criteria
Compensation up to $1200 will be provided for your time and travel

For more information please call 501-227-5061 or 501-227-6179
and ask to speak with Dusty regarding the UP0100 study.